{"transactions":[{"id":3673587,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-05T23:30:05.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":11625,"derivative":{"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0001209191-19-007486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/doc4.xml","form_type":"4"}},{"id":3673586,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-02-05T23:30:05.000Z","date":"2019-02-01","kind":"tax_withholding","acquired":false,"shares":1308,"price":6.96,"value":9103.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4."}],"balance_after":10582,"source":{"system":"sec-edgar","filing":"0001209191-19-007486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/doc4.xml","form_type":"4"}},{"id":3673585,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-02-05T23:30:05.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11890,"source":{"system":"sec-edgar","filing":"0001209191-19-007486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919119007486/doc4.xml","form_type":"4"}},{"id":3720569,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-21T12:31:17.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in two equal annual installments on December 18, 2018 and December 18, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in two equal annual installments on December 18, 2018 and December 18, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":1750,"derivative":{"underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001209191-18-063802","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/doc4.xml","form_type":"4"}},{"id":3720568,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:31:17.000Z","date":"2018-12-18","kind":"tax_withholding","acquired":false,"shares":498,"price":6.3,"value":3137.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4."}],"balance_after":8015,"source":{"system":"sec-edgar","filing":"0001209191-18-063802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/doc4.xml","form_type":"4"}},{"id":3720567,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:31:17.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8513,"source":{"system":"sec-edgar","filing":"0001209191-18-063802","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063802/doc4.xml","form_type":"4"}},{"id":3726271,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-19T01:51:02.000Z","date":"2018-12-15","kind":"exercise","acquired":false,"shares":1013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 15, 2016, the reporting person was granted 8,100 restricted stock units. 50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone. The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 15, 2016, the reporting person was granted 8,100 restricted stock units. 50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone. The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":2025,"derivative":{"underlying":"Common Stock","underlying_shares":1013},"source":{"system":"sec-edgar","filing":"0001209191-18-063367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063367/doc4.xml","form_type":"4"}},{"id":3726270,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-19T01:51:02.000Z","date":"2018-12-15","kind":"tax_withholding","acquired":false,"shares":288,"price":7.31,"value":2105.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4."}],"balance_after":6763,"source":{"system":"sec-edgar","filing":"0001209191-18-063367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063367/doc4.xml","form_type":"4"}},{"id":3726269,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-12-19T01:51:02.000Z","date":"2018-12-15","kind":"exercise","acquired":true,"shares":1013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":7051,"source":{"system":"sec-edgar","filing":"0001209191-18-063367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118063367/doc4.xml","form_type":"4"}},{"id":3940538,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-05-09T20:18:52.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":4050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 15, 2016, the reporting person was granted 8,100 restricted stock units.  50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone.  The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 15, 2016, the reporting person was granted 8,100 restricted stock units.  50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone.  The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":3038,"derivative":{"underlying":"Common Stock","underlying_shares":4050},"source":{"system":"sec-edgar","filing":"0001209191-18-028858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118028858/doc4.xml","form_type":"4"}},{"id":3940537,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-05-09T20:18:52.000Z","date":"2018-05-07","kind":"tax_withholding","acquired":false,"shares":1153,"price":18.1,"value":20869.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4."}],"balance_after":6038,"source":{"system":"sec-edgar","filing":"0001209191-18-028858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118028858/doc4.xml","form_type":"4"}},{"id":3940536,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":160553,"kind":"person","name":"Fair Brett","position":1,"cik":"0001737277","reported_name":"Fair Brett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-05-09T20:18:52.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":4050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":7191,"source":{"system":"sec-edgar","filing":"0001209191-18-028858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919118028858/doc4.xml","form_type":"4"}}]}